THE SHAREHOLDERS’ MEETING OF LUMINEX CORPORATION APPROVED THE MERGER OF LUMINEX WITH A U.S. WHOLLY-OWNED SUBSIDIARY OF DIASORIN
Saluggia – DiaSorin (FTSE MIB: DIA) announces that the Shareholders’ Meeting of Luminex Corporation (“Luminex”; NASDAQ: LMNX), held today, approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin, pursuant to the merger agreement relating to the acquisition of Luminex by DiaSorin, as announced on April 11, 2021. Following the merger, Luminex shareholders will be entitled to receive a cash consideration of $37.00 for each Luminex share held. The transaction is expected to close within the third quarter of 2021.

